Nurix Therapeutics (NRIX)
Nurix Therapeutics (NRIX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- NRIX last traded at $12.85 on 2026-11-20, -5.51% for the session.
- Nurix Therapeutics: market cap $1.40B, revenue $71.78M over the last four quarters, next earnings 2027-01-27.
- Over the past year NRIX returned -10.33%, with a year-to-date return of -32.26%.
Sanofi setback weighs as investors await trial data
Nurix slipped 0.9% today while the S&P 500 and Nasdaq 100 rose, extending a steep monthly decline. Sanofi’s decision to end a partnered drug program remains a recent concern; investors are also looking to upcoming cancer-trial data and Nurix’s next report.
Published 2026-11-19 15:01:41 UTC.